Cancer Home > Bicalutamide

Bicalutamide is a prescription drug used to treat advanced prostate cancer. It comes in tablet form and is taken once a day, preferably at the same time each day. As an androgen receptor inhibitor, it works by blocking the effects of male sex hormones (androgens). Hot flashes, body pain, and weakness are some of the common side effects.

What Is Bicalutamide?

Bicalutamide (Casodex®) is a prescription medication approved for the treatment of advanced metastatic prostate cancer (prostate cancer that has spread to other areas of the body). It is used in combination with another prostate cancer medication that lowers the levels of testosterone in the body.
 
(Click What Is Bicalutamide Used For? for more information on this topic, including possible off-label uses.)
 

Are There Side Effects?

Just like any medicine, bicalutamide can cause side effects. However, not everyone who takes the drug will experience problems. Most people tolerate it quite well.
 
If side effects do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. Serious reactions are less common.
 
Some of the most common side effects of bicalutamide include but are not limited to:
 
(Click Bicalutamide Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
 
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2017 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.